Edward Cantu III MD MSCE
Cardiovascular Surgery
Associate Professor of Surgery, Associate Surgical Director of Lung Transplantation, Director of Lung Transplant Research, Director of Ex Vivo Lung Perfusion, Director of ILD Service Line
Join to View Full Profile
740 S LimestoneSte L304Lexington, KY 40536
Phone+1 859-323-6494
Fax+1 215-614-1861
Dr. Cantu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Edward Cantu III, MD is a thoracic surgeon based in Philadelphia, PA, with a subspecialty in cardiovascular surgery. He has experience in a variety of procedures including adult general thoracic surgery, aortic surgery, minimally invasive cardiac and thoracic surgeries, and thoracic surgical oncology. Dr. Cantu completed his surgical residency and thoracic surgery fellowship at Duke University Hospital and is now an MD at Penn Medicine. He has contributed to multiple publications, including topics on lung transplantation and alpha-1 antitrypsin deficiency. He was involved in a clinical trial on novel lung trial and received a CMS Meaningful Use Stage 1 Certification in 2012-2013.
Education & Training
Duke University HospitalFellowship, Thoracic Surgery - Independent, 2007 - 2010- Duke University HospitalResidency, Surgery, 2000 - 2007
Columbia University Vagelos College of Physicians and SurgeonsClass of 2000
Certifications & Licensure
KY State Medical License 2025 - 2026
PA State Medical License 2010 - 2026
NJ State Medical License 2018 - 2023
NC State Medical License 2000 - 2011
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 1 citationsClinical and System-Level Factors Driving Donor Lung Utilization Decisions: A Qualitative Study.Brittany Koons, James D Mendez, Michaela R Anderson, Edward Cantu, Matthew Hartwig
Annals of the American Thoracic Society. 2025-08-01 - Current intraoperative mechanical circulatory support strategies for bilateral lung transplantation surgery.Omar Toubat, Asad A Usman, Paulo Gregorio, Max Shin, Audrey Spelde
JTCVS Techniques. 2025-06-01 - A Pilot Study to Capture Provider Perspectives on Clinically Relevant Effects in Thoracic Transplant Trials.Edward Cantu, Dane Isenberg, Abigail Marquis, Alyster Alcudia, Sophia Yusuf
American Journal of Respiratory and Critical Care Medicine. 2025-06-01
Journal Articles
- Bidirectional Transfer of Anelloviridae Lineages Between Graft and Host During Lung TransplantationK M Olthoff, J D Christie, D J Lederer, R G Collman, J M Diamond, A Shaked, A R Haas, E Cantu, K Meyer, American journal of transplantation
Press Mentions
ISHLT Elects New Board MembersJanuary 7th, 2021
New-Found Stem Cell Helps Regenerate Lung Tissue After Acute InjuryMarch 1st, 2018
Scientists Isolate Human Lung Progenitor Cells That Repair Alveolar DamageMarch 1st, 2018
Grant Support
- Using Advanced Imaging to Improve Ex Vivo Lung PerfusionUNIVERSITY OF PENNSYLVANIA2024–2028
- Objective lung assessment tools for improved organ use in lung transplantationUNIVERSITY OF PENNSYLVANIA2021–2026
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
